Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Simone Incicco, Salvatore Piano

Clin Mol Hepatol. 2024;30(4):695-697. Published online June 3, 2024

DOI: https://doi.org/10.3350/cmh.2024.0409

View: 1764 Download: 33 Web of Science: 1 Crossref: 1

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2022;28(2):273-275. Published online February 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0036

View: 7654 Download: 248 Web of Science: 3 Crossref: 3

Salvatore Piano, Marta Tonon, Paolo Angeli

Clin Mol Hepatol. 2021;27(3):437-445. Published online January 28, 2021

DOI: https://doi.org/10.3350/cmh.2020.0329

View: 9612 Download: 436 Web of Science: 41 Crossref: 45

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2021;27(1):94-96. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0305

View: 5658 Download: 149 Web of Science: 8 Crossref: 8

1 |

Viewed By 10741	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7576	MAFLD: How is it different from NAFLD?
Viewed By 5463	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4916	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 4851	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Cited By 338	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 305	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 210	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 104	Non-alcoholic fatty liver disease: Definition and subtypes

Search